tradingkey.logo

Novo's Wegovy pill tracks 3,071 prescriptions in first days of launch

ReutersJan 16, 2026 12:41 PM

- Novo Nordisk's NOVOb.CO Wegovy pill hit 3,071 U.S. prescriptions in the first four days after its launch, IQVIA data shared by analysts on Friday showed, as investors closely watch to see if the firm can ram home its first-mover advantage against rival Eli Lilly LLY.N in a competitive weight-loss market.

The data reflects retail prescriptions for oral Wegovy, not those filled through the drugmaker's online NovoCare Pharmacy, so actual prescription numbers will be higher, Barclays analysts said in a note.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI